Professor Kamil R Kranc graduated in medicine from the Medical University of Silesia (Poland) in 2000. He then moved to the University of Oxford to obtain a DPhil in Biochemistry in 2003, followed by ...

We are a world-leading cancer research institute, a charity, and a member institution of the University of London. Public donations and clinical partnerships are helping us to make the discoveries ...

The Royal Marsden NHS Foundation Trust is a world-leading specialist cancer hospital. The Institute of Cancer Research works in close partnership with The Royal Marsden to take the results of our ...

Scientists have developed a machine learning tool that can predict how an aggressive type of breast cancer will respond to treatment, and when it will return.

The Division of Cancer Biology studies the complex interplay of genes, proteins and biological processes that drive the development and growth of cancers. Understanding the many different biological ...

Our academic clinicians bring knowledge of clinical practice into the lab and take laboratory research back into the clinic ...

Using funding from the National Institute for Health Research (NIHR), The Institute of Cancer Research offers training programmes that support NHS doctors to undertake specialty training to also train ...

Clinical trials are the single best way to turn advances in science into patient benefits. The ICR has a vision that a suitable trial should be made available for every person with cancer who wants to ...

The Centre for Molecular Pathology is a collaborative initiative between The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, aiming to identify the molecular mechanisms that ...

In 2019 we released a Cancer drug manifesto, calling for action to speed up access to innovative cancer drugs and propose a number of ways we can ensure the most innovative new cancer drugs are ...